These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5573439)

  • 21. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
    Amstein R; Fetkovska N; Bühler FR
    J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggregation of duck thrombocytes by 5-hydroxytryptamine.
    Belamarich FA; Simoneit LW
    Microvasc Res; 1973 Sep; 6(2):229-34. PubMed ID: 4748022
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR; Colley DG; Des Prez RM
    J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.
    Weiss HJ; Tschopp TB; Rogers J; Brand H
    J Clin Invest; 1974 Aug; 54(2):421-33. PubMed ID: 4847252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The measurement of intravascular aggregation by continuous platelet counting.
    Smith GM; Freuler F
    Bibl Anat; 1973; 12():229-34. PubMed ID: 4790356
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet serotonin in patients with analgesic-induced headache.
    Srikiatkhachorn A; Anthony M
    Cephalalgia; 1996 Oct; 16(6):423-6. PubMed ID: 8902251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin infusions inhibit sensory input from the dural vasculature.
    Lambert GA; Shimomura T; Boers PM; Gordon V; Donaldson C; Zagami AS
    Cephalalgia; 1999 Sep; 19(7):639-50. PubMed ID: 10524657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood platelets as models for central 5-hydroxytryptaminergic neurons.
    Pletscher A; Laubscher A; Graf M; Saner A
    Ann Biol Clin (Paris); 1979; 37(1):35-9. PubMed ID: 443611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet serotonin measures in migraine.
    Jernej B; Vladić A; Cicin-Sain L; Hranilović D; Banović M; Balija M; Bilić E; Sucić Z; Vukadin S; Grgicević D
    Headache; 2002; 42(7):588-95. PubMed ID: 12482210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploration of mechanisms of amine storage in the dense bodies of human platelets.
    Costa JL; Eanes ED
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):347-66. PubMed ID: 6095385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet 5-hydroxytryptamine and adenine nucleotides, serum arginylesterase and plasma 11-hydroxycorticosteroids in migraine.
    Hinterberger H; Anthony M; Vagholkar MK
    Clin Sci; 1968 Apr; 34(2):271-6. PubMed ID: 5653687
    [No Abstract]   [Full Text] [Related]  

  • 32. The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology.
    Pletscher A
    Int J Cardiol; 1987 Feb; 14(2):177-88. PubMed ID: 3818134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of platelet Met-enkephalin, but not serotonin, in migraine. A platelet response unique to migraine patients?
    Ferrari MD; Odink J; Frölich M; Tapparelli C; Portielje JE
    J Neurol Sci; 1989 Oct; 93(1):51-60. PubMed ID: 2809630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets.
    Baumgartner HR; Born GV
    J Physiol; 1969 Apr; 201(2):397-408. PubMed ID: 5780549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus.
    Pietraszek MH; Takada Y; Takada A; Fujita M; Watanabe I; Taminato A; Yoshimi T
    Thromb Res; 1992 Jun; 66(6):765-74. PubMed ID: 1519234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migraine: a platelet disorder.
    Hanington E; Jones RJ; Amess JA; Wachowicz B
    Lancet; 1981 Oct; 2(8249):720-3. PubMed ID: 6116859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The action of reserpine on the concentration of 5-hydroxytryptamine, epinephrine and norepinephrine in the venous blood of migraine patients].
    Genefke IK; Bryndum B; Dalsgaard-Nielsen T; Fog-Moller F
    Minerva Med; 1976 Jun; 67(28):1876-82. PubMed ID: 934535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance.
    Fetkovska N; Pletscher A; Ferracin F; Amstein R; Buhler FR
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():105-9. PubMed ID: 1704794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in density and accumulation of serotonin by human aging platelets.
    Mezzano D; Aranda E; Rodríguez S; Foradori A; Lira P
    Am J Hematol; 1984 Jul; 17(1):11-21. PubMed ID: 6741929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
    Amstein R; Fetkovska N; Pletscher A; Bühler FR
    J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.